Survivors’ patient-reported symptoms of neck disability and swallowing dysfunction were prospectively collected from March 2017 to May 2018. Neck disability and swallowing dysfunction were measured using the Neck Disability Index and Eating Assessment Tool (EAT-10), respectively. Linear regression was used to analyze the association between neck disability and swallowing dysfunction.
Results
A total of 179 survivors, predominantly male (n = 130, 72.6%) with an average age of 64.64 ± 9.91 years, were included in the analysis. Primary cancer sites were oropharynx (n = 85, 47.5%), oral cavity (n = 59, 33.0%), and larynx/hypopharynx (n = 35, 19.5%). Mean EAT-10 score was 10.07 ± 10.89 (range = 0-40; >2 indicative of swallowing dysfunction). Survivors treated for early stage cancer had lower EAT-10 scores than those with advanced stage (early = 3.55 ± 7.46; advanced = 11.95 ± 11.02, P < .001). After controlling for age, time since treatment, American Joint Committee on Cancer stage, and treatment modality, the EAT-10 score for patients with mild neck disability was 6.88 (95% confidence interval [CI], 3.71-10.06; P < .001) points higher than those without neck disability, and the score for those with moderate-complete neck disability was 13.65 (95% CI, 9.47-17.83; P < .001) points higher than those without neck disability.
Conclusions
Swallowing dysfunction is a commonly recognized effect of HNC treatment. The prevalence and burden of neck disability are shown to be highly correlated with swallowing dysfunction. These results support the need for comprehensive, multidisciplinary rehabilitation interventions for patients with HNC.
SiegelRLMillerKDJemalA.Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7-30.
2.
MurphyCTGallowayTJHandorfEA, et al. Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United States. J Clin Oncol. 2016;34(2):169-178.
3.
NwizuTAdelsteinD.Pharmacotherapy of head and neck cancer. Expert Opin Pharmacother. 2015;16(16):2409-2422.
4.
SemrauR.The role of radiotherapy in the definitive and postoperative treatment of advanced head and neck cancer. Oncol Res Treat. 2017;40(6):347-352.
5.
TeymoortashAFerlitoAHalmosGB.Treatment in elderly patients with head and neck cancer. HNO. 2016;64(4):217-220.
6.
MarurSForastiereAA.Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2016;91(3):386-396.
7.
TrottiAPajakTFGwedeCK, et al. TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol. 2007;8(7):613-624.
8.
GivensDJKarnellLHGuptaAK, et al. Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2009;135(12):1209-1217.
9.
McDonaldMWLiuYMooreMGJohnstonePAS. Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy. Radiat Oncol. 2016;11:32.
10.
MachtayMMoughanJTrottiA, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008;26(21):3582-3589.
11.
HammarstedtLLindquistDDahlstrandH, et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer. 2006;119(11):2620-2623.
12.
ChaturvediAKEngelsEAPfeifferRM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294-4301.
13.
AngKKHarrisJWheelerR, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24-35.
14.
FakhryCZhangQNguyen-TanPF, et al. Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. J Clin Oncol. 2014;32(30):3365-3373.
15.
NilsenMLLyuLBelskyMA, et al. Impact of neck disability on health-related quality of life among head and neck cancer survivors. Otolaryngol Head Neck Surg. 2020;162(1):64-72.
16.
ChaturvediAKAndersonWFLortet-TieulentJ, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013;31(36):4550-4559.
17.
SroussiHYEpsteinJBBensadounR-J, et al. Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis. Cancer Med. 2017;6(12):2918-2931.
18.
JiYBSongCMBangHSParkHJLeeJYTaeK.Functional and cosmetic outcomes of robot-assisted neck dissection by a postauricular facelift approach for head and neck cancer. Oral Oncol. 2017;70:51-57.
19.
ManikantanKKhodeSSayedSI, et al. Dysphagia in head and neck cancer. Cancer Treat Rev. 2009;35(8):724-732.
20.
MalageladaJ-RBazzoliFBoeckxstaensG, et al. World Gastroenterology Organisation global guidelines. J Clin Gastroenterol. 2015;49(5):370-378.
21.
KotzTCostelloRLiYPosnerMR.Swallowing dysfunction after chemoradiation for advanced squamous cell carcinoma of the head and neck. Head Neck. 2004;26(4):365-372.
22.
WallLRWardECCartmillBHillAJ.Physiological changes to the swallowing mechanism following (chemo)radiotherapy for head and neck cancer: a systematic review. Dysphagia. 2013;28(4):481-493.
23.
MartinBWCorlewMWoodH, et al. The association of swallowing dysfunction and aspiration pneumonia. Dysphagia. 1994;9(1):1-6.
24.
MurphyBAGilbertJ.Dysphagia in head and neck cancer patients treated with radiation: assessment, sequelae, and rehabilitation. Semin Radiat Oncol. 2009;19(1):35-42.
25.
CarrollWRLocherJLCanonCLBohannonIAMcCollochNLMagnusonJS.Pretreatment swallowing exercises improve swallow function after chemoradiation. Laryngoscope. 2008;118(1):39-43.
26.
NeumannSBartolomeGBuchholzDProsiegelM.Swallowing therapy of neurologic patients: correlation of outcome with pretreatment variables and therapeutic methods. Dysphagia. 1995;10(1):1-5.
27.
OllivereBDuceKRowlandsGHarrisonPO’ReillyBJ.Swallowing dysfunction in patients with unilateral vocal fold paralysis: aetiology and outcomes. J Laryngol Otol. 2006;120(1):38-41.
28.
ShinnEHBasen-EngquistKBaumG, et al. Adherence to preventive exercises and self-reported swallowing outcomes in post-radiation head and neck cancer patients. Head Neck. 2013;35(12):1707-1712.
29.
RussiEGCorvòRMerlottiA, et al. Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: review and recommendations of the supportive task group of the Italian Association of Radiation Oncology. Cancer Treat Rev. 2012;38(8):1033-1049.
EdmondsMFMcGuireDB.Treatment adherence in head and neck cancer patients undergoing radiation therapy: challenges for nursing. J Radiol Nurs. 2007;26(3):87-92.
32.
YuanHLiHMaH, et al. Genetic polymorphisms in key DNA repair genes and risk of head and neck cancer in a Chinese population. Exp Ther Med. 2012;3(4):719-724.
33.
HowrenMBChristensenAJKarnellLHFunkGF.Health-related quality of life in head and neck cancer survivors: impact of pretreatment depressive symptoms. Heal Psychol. 2010;29(1):65-71.
34.
TribiusSRaguseMVoigtC, et al. Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer. Strahlenther Onkol. 2015;191(6):501-510.
35.
CarrSDBowyerDCoxG.Upper limb dysfunction following selective neck dissection: a retrospective questionnaire study. Head Neck. 2009;31(6):789-792.
36.
van WilgenCPDijkstraPUvan der LaanBFAMPlukkerJTRoodenburgJLN.Morbidity of the neck after head and neck cancer therapy. Head Neck. 2004;26(9):785-791.
37.
van WouweMde BreeRKuikDJ, et al. Shoulder morbidity after non-surgical treatment of the neck. Radiother Oncol. 2009;90(2):196-201.
38.
ChengP-TLinY-HHaoS-PYehAR-M. Objective comparison of shoulder dysfunction after three neck dissection techniques. Ann Otol Rhinol Laryngol. 2000;109(8):761-766.
39.
GhiamMKMannionKDietrichMSStevensKLGilbertJMurphyBA.Assessment of musculoskeletal impairment in head and neck cancer patients. Support Care Cancer. 2017;25(7):2085-2092.
40.
KraaijengaSACOskamIMvan der MolenLHamming-VriezeOHilgersFJMvan den BrekelMWM. Evaluation of long term (10-years+) dysphagia and trismus in patients treated with concurrent chemo-radiotherapy for advanced head and neck cancer. Oral Oncol. 2015;51(8):787-794.
41.
van der MolenLvan RossumMABurkheadLMSmeeleLEHilgersFJM.Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review. Eur Arch Otorhinolaryngol. 2009;266(6):889-900.
42.
Louise KentMBrennanMTNollJL, et al. Radiation-induced trismus in head and neck cancer patients. Support Care Cancer. 2008;16(3):305-309.
43.
OwenDIqbalFPollockBE, et al. Long-term follow-up of stereotactic radiosurgery for head and neck malignancies. Head Neck. 2015;37(11):1557-1562.
44.
García-PerisPParónLVelascoC, et al. Long-term prevalence of oropharyngeal dysphagia in head and neck cancer patients: impact on quality of life. Clin Nutr. 2007;26(6):710-717.
45.
GaneEMO’LearySPHattonALPanizzaBJMcPhailSM.Neck and upper limb dysfunction in patients following neck dissection: looking beyond the shoulder. Otolaryngol Neck Surg. 2017;157(4):631-640.
46.
GaneEMMcPhailSMHattonALPanizzaBJO’LearySP.The relationship between physical impairments, quality of life and disability of the neck and upper limb in patients following neck dissection. J Cancer Surviv. 2018;12(5):619-631.
47.
BlasimannADauphineeSWStaalJB.Translation, cross-cultural adaptation, and psychometric properties of the german version of the hip disability and osteoarthritis outcome score. J Orthop Sport Phys Ther. 2014;44(12):989-997.
48.
MurphyBAGilbertJ.Dysphagia in head and neck cancer patients treated with radiation: assessment, sequelae, and rehabilitation. Semin Radiat Oncol. 2009;19(1):35-42.
49.
AlbergottiWGJordanJAnthonyK, et al. A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx. Cancer. 2017;123(16):3132-3140.
50.
WangKAmdurRJMendenhallWM, et al. Impact of post-chemoradiotherapy superselective/selective neck dissection on patient reported quality of life. Oral Oncol. 2016;58:21-26.
51.
AgarwalJDuttaDPalweVGuptaTLaskarSGBudrukkarA, et al. Prospective subjective evaluation of swallowing function and dietary pattern in head and neck cancers treated with concomitant chemo-radiation. J Cancer Res Ther. 2005;6:15-21.
52.
CheneyDMSiddiquiMTLittsJKKuhnMABelafskyPC.The ability of the 10-Item Eating Assessment Tool (EAT-10) to predict aspiration risk in persons with dysphagia. Ann Otol Rhinol Laryngol. 2015;124(5):351-354.
53.
RofesLArreolaVMukherjeeRClavéP.Sensitivity and specificity of the Eating Assessment Tool and the Volume-Viscosity Swallow Test for clinical evaluation of oropharyngeal dysphagia. Neurogastroenterol Motil. 2014;26(9):1256-1265.
54.
VernonHMiorS.The Neck Disability Index: a study of reliability and validity. J Manipulative Physiol Ther. 1991;14(7):409-415.
55.
ClelandJAChildsJDWhitmanJM.Psychometric properties of the Neck Disability Index and Numeric Pain Rating Scale in patients with mechanical neck pain. Arch Phys Med Rehabil. 2008;89(1):69-74.
56.
ClelandJAFritzJMWhitmanJMPalmerJA.The reliability and construct validity of the Neck Disability Index and patient specific functional scale in patients with cervical radiculopathy. Spine (Phila Pa 1976). 2006;31(5):598-602.
57.
PoolJJMOsteloRWJGHovingJLBouterLMde VetHCW. Minimal clinically important change of the Neck Disability Index and the Numerical Rating Scale for patients with neck pain. Spine (Phila Pa 1976). 2007;32(26):3047-3051.
58.
YoungBAWalkerMJStrunceJBBoylesREWhitmanJMChildsJD.Responsiveness of the Neck Disability Index in patients with mechanical neck disorders. Spine J. 2009;9(10):802-808.
59.
KaurPPannuASinghS.Assessment of swallowing and neck dysfunction post radiotherapy/chemoradiotherapy in head and neck cancer patients. Biometrics Biostat Int J. 2016;3(3).
60.
OjoBGendenEMTengMSMilburyKMisiukiewiczKJBadrH.A systematic review of head and neck cancer quality of life assessment instruments. Oral Oncol. 2012;48(10):923-937.
61.
HainsFWaalenJMiorS.Psychometric properties of the neck disability index. J Manipulative Physiol Ther. 1998;21(2):75-80.
62.
MacDermidJCWaltonDMAveryS, et al. Measurement properties of the Neck Disability Index: a systematic review. J Orthop Sport Phys Ther. 2009;39(5):400-417.
63.
BelafskyPCMouadebDAReesCJ, et al. Validity and reliability of the Eating Assessment Tool (EAT-10). Ann Otol Rhinol Laryngol. 2008;117(12):919-924.
64.
ArreseLCCarrauRPlowmanEK.Relationship between the Eating Assessment Tool-10 and objective clinical ratings of swallowing function in individuals with head and neck cancer. Dysphagia. 2017;32(1):83-89.
65.
DenaroNMerlanoMCRussiEG.Dysphagia in head and neck cancer patients: pretreatment evaluation, predictive factors, and assessment during radio-chemotherapy, recommendations. Clin Exp Otorhinolaryngol. 2013;6(3):117-126.
66.
EisbruchALydenTBradfordCR, et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol. 2002;53(1):23-28.
67.
KweonSKooBSJeeS.Change of swallowing in patients with head and neck cancer after concurrent chemoradiotherapy. Ann Rehabil Med. 2016;40(6):1100-1107.
68.
TeymoortashAHochSEivaziBWernerJA.Postoperative morbidity after different types of selective neck dissection. Laryngoscope. 2010;120(5):924-929.
69.
PopescuBBerteşteanuSVGGrigoreRScăunaşuRPopescuCR.Functional implications of radical neck dissection and the impact on the quality of life for patients with head and neck neoplasia. J Med Life. 2012;5(4):410-413.
70.
LanišnikBŽitnikLLevartPŽargiMRodiZ.The impact on post-operative shoulder function of intraoperative nerve monitoring of cranial nerve XI during modified radical neck dissection. Eur Arch Otorhinolaryngol. 2016;273(12):4445-4451.
71.
PauloskiBRRademakerAWLogemannJA, et al. Pretreatment swallowing function in patients with head and neck cancer. Head Neck. 2000;22(5):474-482.
72.
EckertAWWickenhauserCSalinsPCKapplerMBukurJSeligerB.Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma. J Transl Med. 2016;14(1):85.
73.
JungKYChoSWKimYA, et al. Cancers with higher density of tumor-associated macrophages were associated with poor survival rates. J Pathol Transl Med. 2015;49(4):318-324.
74.
PawlikTMDelmanKAVautheyJ-N, et al. Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transplant. 2005;11(9):1086-1092.
75.
JensenKLambertsenKGrauC.Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: frequency, intensity and correlation with dose and volume parameters. Radiother Oncol. 2007;85(1):74-82.
